Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 23.03 CNY 0.7% Market Closed
Market Cap: 7.1B CNY

Sirio Pharma Co Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sirio Pharma Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Net Income (Common)
ÂĄ345.5m
CAGR 3-Years
19%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Net Income (Common)
ÂĄ2.3B
CAGR 3-Years
-6%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
Proya Cosmetics Co Ltd
SSE:603605
Net Income (Common)
ÂĄ1.6B
CAGR 3-Years
31%
CAGR 5-Years
29%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Net Income (Common)
ÂĄ652.8m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
3%
S
Shanghai Chicmax Cosmetic Co Ltd
HKEX:2145
Net Income (Common)
ÂĄ781.2m
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Net Income (Common)
ÂĄ2.1B
CAGR 3-Years
36%
CAGR 5-Years
30%
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Market Cap
7.1B CNY
Industry
Consumer products

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
25.68 CNY
Undervaluation 10%
Intrinsic Value
Price

See Also

What is Sirio Pharma Co Ltd's Net Income (Common)?
Net Income (Common)
345.5m CNY

Based on the financial report for Sep 30, 2025, Sirio Pharma Co Ltd's Net Income (Common) amounts to 345.5m CNY.

What is Sirio Pharma Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
11%

Over the last year, the Net Income (Common) growth was 3%. The average annual Net Income (Common) growth rates for Sirio Pharma Co Ltd have been 19% over the past three years , 11% over the past five years .

Back to Top